Trials / Completed
CompletedNCT01119313
Study to Investigate Skin Conditions and Patient Assessment of LAS 41002 in the Treatment of Atopic Eczema
A Phase II, Single-center, Randomized, Controlled, Double-blind Study to Assess Effects on Skin Conditions and Patient Reported Outcome of a Topical Formulation Containing LAS41002 on Lesional Skin in Patients With Atopic Eczema
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Almirall, S.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of the study is an intra-individual comparison of skin conditions in addition to a patient based assessment of product appearance in the topical treatment of atopic eczema.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LAS 41002 | LAS 41002, once daily |
| DRUG | Active | Active, once daily |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2010-05-07
- Last updated
- 2010-07-12
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT01119313. Inclusion in this directory is not an endorsement.